| Definition: | CMO, or cetyl myristoleate, is a fatty acid which is
absorbed in the intestines after being orally ingested. It can be
extracted from living tissue or synthetically produced. CMO occurs in
certain mice species, male beavers and in sperm whale oil. Currently, it
is being produced synthetically without using any animal extracts.
Simply stated, CMO has the ability to inhibit the symptoms of arthritic
disease including pain, and inflammation and is also considered an
immunizing agent against the development of rheumatoid arthritis.
|
| Applications: | Osteoarthritis, psoriatic arthritis, lupus, back pain, joint
injuries, Reiter's Syndrome, autoimmune diseases, ankylosing spondylitis
and rheumatoid arthritis (several reports claim that CMO is also
effective for rheumatoid arthritis as both a preventative and
therapeutic agent) |
| Recommendations: | Generally, a CMO protocol involves a three-to-six
week course of treatment. A minimum of thirty days is recommended for
maximum efficacy. Therapy typically involves taking a recommended
number of capsules or liquid several times a day with a break of several
days and eventual resumption of treatment until the entire amount of
CMO has been consumed. Note: If you have trouble digesting and
assimilating fats, taking lipase may help to ensure proper absorption of
CMO which is a fat-based compound. Taking fat-absorbing supplements
like chitosan may interfere with the proper assimilation of CMO.
|
